Jorge Mestre-Ferrandiz is an independent health economics researcher and consultant since 2017, based in Madrid, Spain. He spent 15 years at The Office of Health Economics, starting as an Industrial Economist and finishing as Director of Consulting. Jorge has nearly 20 years’ experience consulting to the life sciences industry and related non-profit organisations and his clients and collaborators have included many global top 30 pharmaceutical companies, public sector organisations, and a range of NGOs. He specialises in the economics of the industry, the pricing and reimbursement of medicines, the impact of public policy on innovation, market access, the economics of rare diseases and orphan medicines, the economics of antimicrobial resistance (AMR), and pharmaceutical product portfolios.
Jorge has a PhD in Economic Analysis from the University Autonoma of Barcelona, has published over 60 papers on health economics and is regularly invited to speak on related topics at academic and commercial international conferences. He is also a Visiting Fellow at OHE, member of the Editorial Board of Applied Health Economics and Health Policy, and member of the Advisory Board of Fundación Weber and Fundació HiTT respectively. Jorge is also an advisor to The Comite Asesor de la Prestacion Farmacéutica del SNS (CAPF) in Spain.
Jorge also has many years’ experience in researching and consulting about incentives to encourage the development and use of orphan medicinal products (OMPs). He has co-authored and led a number of papers and projects on the topic, including analysing orphan medicine expenditure in Europe, comparing access to OMPs across a selection of European countries and Spain specifically, assessing the effects of the EU OMP legislation, and took part in a multi-decision criteria analysis to explore factors that could be used to assess OMPs in Spain.
SPEAKER: INNOVATION FOR SMALL POPULATIONS: WHAT SHOULD WE PAY FOR?